[1] Dacie J. The auto-immune haemolytic anaemias: Introduc- tion. In: Dacie J, editor. The haemolytic anaemias., vol. 3 London: Churchill Livingstone; 1992. p 1–5.
[2] Petz LD, Garratty G. Classification and clinical characteristics of autoimmune hemolytic anemias. In: Petz LD, Garratty G, editors. Immune hemolytic anemias. Philadelphia, PA: Churchill Livingstone; 2004. p 61–131.
[3] Berentsen S, Ulvestad E, Langholm R, Beiske K, Hjorth- Hansen H, Ghanima W, Sorbo JH, Tjonnfjord GE. Primary chronic cold agglutinin disease: A population based clinical study of 86 patients. Haematologica 2006;91(4):460–466.
[4] Ulvestad E, Berentsen S, Bo K, Shammas FV. Clinical immunology of chronic cold agglutinin disease. Eur J Haematol 1999;63(4):259– 266.
[5] Gertz MA. Cold hemolytic syndrome. Hematology Am Soc Hematol Educ Program 2006;19– 23.
[6] Landsteiner K. U  ̈ ber Beziehungen zwischen dem Blutserum und den Ko  ̈ rperzellen. Mu  ̈ nchener medizinische Wochens- chrift 1903;50:1812 –1814.
[7] Clough MC, Richter IM. A study of an auto-agglutinin occurring in human serum. Johns Hopkins Hosp Bull 1918;29:86 –93.
[8] Rosenthal F, Corten M. U  ̈ ber das Ph  ̈nomen der Auto- h  ̈magglutination und u  ̈ ber die Eigenscaften der K  ̈lteh  ̈mag- glutinine. Folia Haematol (Leipzig) 1937;58:64– 90.
[9] Dacie J. Auto-immune haemolytic anaemia (AIHA): Cold antibody syndromes I: Idiopathic types: Clinical presentation and haematological and serological findings. In: Dacie J, editor. The haemolytic anaemias., vol. 3 London: Churchill Livingstone; 1992. p 210– 239.
[10] Schubothe H. The cold hemagglutinin disease. Semin Hematol 1966;3(1):27– 47.
[11] Olesen H. Thermodynamics of the cold agglutinin reaction. Scand J Clin Lab Invest 1966;18(1):1–15.
[12] Rosse WF, Adams JP. The variability of hemolysis in the cold agglutinin syndrome. Blood 1980;56(3):409– 416.
[13] Zilow G, Kirschfink M, Roelcke D. Red cell destruction in cold agglutinin disease. Infusionsther Transfusionsmed 1994;21(6):410–415.
[14] Rorvik K. The syndrome of high-titre cold haemagglutination; a survey and a case report. Acta Med Scand 1954;148(4): 299– 308.
[15] Jaffe CJ, Atkinson JP, Frank MM. The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man. J Clin Invest 1976;58(4):942–949.
[16] Kirschfink M, Knoblauch K, Roelcke D. Activation of complement by cold agglutinins. Infusionsther Transfu- sionsmed 1994;21(6):405–409.
[17] Nydegger UE, Kazatchkine MD, Miescher PA. Immuno- pathologic and clinical features of hemolytic anemia due to cold agglutinins. Semin Hematol 1991;28(1):66 –77.
[18] Gertz MA. Cold agglutinin disease. Haematologica 2006; 91(4):439–441.
[19] Dacie J. Treatment and prognosis of cold-antibody AIHA. In: Dacie J, editor. The haemolytic anaemias., vol. 3 London: Churchill Livingstone; 1992. p 502 –508.
[20] Petz LD, Garratty G. Management of autoimmune hemolytic anemias. In: Petz LD, Garratty G, editors. Immune hemolytic anemias. Philadelphia, PA: Churchill Livingstone; 2004. p 401– 458.
[21] Sokol RJ, Hewitt S, Stamps BK. Autoimmune haemolysis: An 18-year study of 865 cases referred to a regional transfusion centre. Br Med J (Clin Res Ed) 1981;282(6281):2023– 2027.